OBEFYSA: Physical Exercise in Obesity for Health and Quality of Life.

Sponsor
Universidad Pablo de Olavide (Other)
Overall Status
Recruiting
CT.gov ID
NCT05713461
Collaborator
University of Seville (Other)
50
1
2
6.3
8

Study Details

Study Description

Brief Summary

This project aims to develop an intervention on healthy habits based on physical exercise and nutritional education in people with obesity.

It is accepted that exercise and nutrition are keys to controlling body weight. People with obesity frequently present with metabolic syndrome and a low-grade inflammatory state.

It is not known what should be the most effective training load/dose (duration, intensity, type of exercise) to improve health indicators related to metabolic syndrome and lipo-inflammation, and body composition in people with obesity.

A large-scale randomized controlled trial (RCT) will be essential to better understand the type and characteristics of training load/dose most effective in counteracting the detrimental effects of obesity.

The aim of this trial in 50 obese women was to answer the following questions:
  • Does the training program improve physical fitness?

  • Does the training program improve body composition?

  • Does the training program improve the state of chronic low-grade inflammation?

  • Does the training program improve the quality of life and perceived health?

  • Do people with obesity and metabolic syndrome respond in the same way to training?

  • what is the effect of four weeks of detraining?

Condition or Disease Intervention/Treatment Phase
  • Behavioral: exercise training program
  • Behavioral: Feeding training
N/A

Detailed Description

A female single group, 2-armed ( people with obesity and metabolic syndrome vs people with obesity without metabolic syndrome), investigator-blinded, trial.

The study will last 17 weeks. Week 1 (testing 1: pretest); weeks 2-11 (Intervention: interval training program); week 12 (testing 3: postest); weeks 13-16 (detraining period); week 17 (testing 3: detraining test)

Participants will be allocated (1:1) regarding metabolic syndrome Behavioural: exercise training program Adapted Interval Training Intervention, three days a week, 10 weeks.

Warm-up ≃ 10': Joint mobility and cardiovascular activation.

Main part ≃ 45 min.:

Resistance training circuit for strengthening the main muscle groups.

  • Shoulder muscles

  • Pectoral muscles

  • Knee Flexor-extensor muscles

  • hip flexor extensor muscles Between 50-70% 1 RM (estimated). Repetitions 1-2 RIR (Repetition in Reserve). Load Intensity was controlled through RPE (OMNI-RES Scale) between 7-8 out of 10.

The training load will increase while maintaining the same intensity.

Cool down ≃ 5' Flexibility and CORE

Behavioural: Feeding training Two workshops on healthy eating habits (Week 1 and week 5). Food Frequency Questionnaires (weekly). Feedback weekly Mediterranean Diet Adherence Screener (MEDAS) The dietary intervention will be based on the nutritional recommendations based on the Mediterranean diet, according to the evidence from the PREDIMED trial.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
To compare the effects of an interval training program in obese women with metabolic syndrom vs obese women without metabolic syndromTo compare the effects of an interval training program in obese women with metabolic syndrom vs obese women without metabolic syndrom
Masking:
Double (Participant, Investigator)
Masking Description:
Participants do not know if they have metabolic syndrom Physical training supervisors do not know if participants have metabolic syndrom
Primary Purpose:
Treatment
Official Title:
Effects of a Physical Exercise Program Adapted to People With Obesity on Health Indicators and Quality of Life.
Actual Study Start Date :
Oct 26, 2022
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
May 5, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: obese women without metabolic syndrome

Women with obesity and without metabolic syndrome

Behavioral: exercise training program
Adapted Interval Training Intervention, three days a week, 10 weeks. Warm-up 10': Joint mobility and cardiovascular activation Main part: Resistance training circuit for strengthening the main muscle groups. Cool down Flexibility and CORE
Other Names:
  • interval training program
  • Behavioral: Feeding training
    Two workshops on healthy eating habits (Week 1 and week 5). Food Frequency Questionnaires (weekly). Feedback weekly. Mediterranean Diet Adherence Screener (MEDAS). The dietary intervention will be based on the nutritional recommendations based on the Mediterranean diet, according to the evidence from the PREDIMED trial.

    Experimental: obese women with metabolic syndrome

    Women with obesity and with metabolic syndrome

    Behavioral: exercise training program
    Adapted Interval Training Intervention, three days a week, 10 weeks. Warm-up 10': Joint mobility and cardiovascular activation Main part: Resistance training circuit for strengthening the main muscle groups. Cool down Flexibility and CORE
    Other Names:
  • interval training program
  • Behavioral: Feeding training
    Two workshops on healthy eating habits (Week 1 and week 5). Food Frequency Questionnaires (weekly). Feedback weekly. Mediterranean Diet Adherence Screener (MEDAS). The dietary intervention will be based on the nutritional recommendations based on the Mediterranean diet, according to the evidence from the PREDIMED trial.

    Outcome Measures

    Primary Outcome Measures

    1. Change in low-grade chronic inflammation [from baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      Plasma levels of inflammatory and lipoinflammatory markers Multiplex Quantitative measurement of 40 human adipokines in plasma (cytokine antibody arrays (pg/ml) : Adiponectin Adipsin AgRP ANGPTL4 BDNF Chemerin CRP GH IFNg IGFBP-1 IGFBP-2 IGF-I IL-10 IL-12p40 IL-12p70 IL-1b IL-1ra IL-6 IL-8 Insulin Leptin Lipocalin-2 MSPa OPG PAI-1 PDGF-BB Pepsinogen 1 Pepsinogen 2 Procalcitonin Prolactin RANTES RBP4 Resistin SAA TGFb1 TSP-1 TNF RI TNF RII TNFa VEGF

    2. Change in body composition [from baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      Body composition by DEXA. Main body composition components: Body Fat Mass (g) Body Lean Mass (g) Body Bone mineral content (g) Body Total mass (g) Estimated Visceral Adipose Tissue (g) BMI: kg/m^2

    3. Change in physical fitness (resistance; muscular strength) [from baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      Maximum dynamic strength of the upper body (bench press; kg) Lower body maximal dynamic strength (leg press; kg) Grip maximal isometric strength (handgrip: kg)

    4. Change in physical fitness (aerobic power; VO2max) [From baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      Aerobic power. VO2 max. (estimated from the 6-minute walk test; ml/kg/min)

    5. Change in physical fitness (Coordination; balance) [From baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      Balance test one leg (seconds)

    6. Change in perceived health and perceived quality of life [from baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      perceived health by questionnaire (SF-12). The SF-12 response options are Likert-type scales that assess intensity or frequency. The number of response options ranges from three to six, depending on the item, and each question receives a value that is later transformed into a scale from 0 to 100.

    7. Change in healthy eating habits [from baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      Mediterranean Diet Adherence Screener (MEDAS). MEDAS consists of 12 questions on food consumption frequency and 2 questions on food intake habits considered characteristic of the Spanish Mediterranean diet. Each question was scored 0 or 1.

    Secondary Outcome Measures

    1. Change eating habits [Every week, from baseline (0 weeks) to follow-up (10 weeks)]

      Food Frequency Questionnaires (weekly). Recording the frequency of food consumption per week

    2. Change in Biochemistry Determinations In Plasma (lipidic profile) [From baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      LIPIDIC PROFILE Total Cholesterol (mg/dl) HDL Cholesterol (mg/dl) LDL Cholesterol (mg/dl) Triglycerides (mg/dl)

    3. Change in Biochemistry Determinations In Plasma (glucose metabolism) [From baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      Glycosylated Hemoglobin A1c (%) Insulin (uU/ml) Glucose (mg/dl) Insulin Resistance. HOMA-IR = (fasting insulin (uU/ml) * fasting glucose (mg/dl)) / 405

    4. Change in Biochemistry Determinations In Plasma (Enzymes of fatigue or muscular damage) [From baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      ENZYMES (Fatigue or muscular damage) Creatine Kinase (UI/L) Transaminases (GOT/AST, GPT/ALT, GGT; UI/L ) C-Reactive Protein (mg/l)

    5. Change in Biochemistry Determinations In Plasma (protein metabolism) [From baseline ( 0 weeks) to follow-up (10 weeks) and detraining effects (after 4 weeks sedentary lifestyle)]

      PROTEIN METABOLISM Uric Acid (mg/dl) Urea (mg/dl) Creatinine (mg/dl) Bilirubin (mg/dl)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    35 Years to 65 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • The recruitment of participants would be carried out through advertising in the press, social networks, and electronic media.

    Main inclusion criteria

    • Sex: Female

    • Caucasian

    • Age. women from 35 years to 65 years.

    • BMI: >29

    • Abdominal perimeter: >90 cm women

    • No known Diabetes

    • No known cancer

    • No Known lung disease

    • No known cardiovascular disease

    • No known thyroid disease

    • No known liver disease

    • No known autoimmune disease

    • No other endocrine disorder causes obesity

    • No current treatment with anti-obesity medication

    • No current treatment with anti-inflammatory medication

    • No weight loss of > 5kg within the last 6 months

    • No diagnosis of depression or treatment with anti-depressive medication, ongoing or within the last three months before enrolment

    • No diagnosis of psychiatric disorder or treatment with antipsychotic medication

    • No history of suicidal behavior or ideations within the last three months before enrolment

    • No previous surgical treatment for obesity

    • Not pregnant/considering pregnancy

    • No functional impairments that prevent the performance of intensive exercise

    • Declare a sedentary lifestyle ((< 1,5 hours of structured physical activity per week at moderate intensity)

    • No participation in other research intervention studies

    • Signed informed consent.

    Exclusion Criteria:
    • Diagnosis of pathology that involves an inflammatory process in the last year.

    • Objective findings that contraindicate participation in intensive exercise

    • The language barrier, mental incapacity, unwillingness or inability to understand the instruction of the study

    • Not completing 75% of the training sessions

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CIRFD Universidad Pablo de Olavide Sevilla Spain 41013

    Sponsors and Collaborators

    • Universidad Pablo de Olavide
    • University of Seville

    Investigators

    • Principal Investigator: Jose A Gonzalez-Jurado, PhD, Universidad Pablo de Olavide de Sevilla

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    José Antonio González Jurado, PhD, Universidad Pablo de Olavide
    ClinicalTrials.gov Identifier:
    NCT05713461
    Other Study ID Numbers:
    • UPO-1381609
    First Posted:
    Feb 6, 2023
    Last Update Posted:
    Feb 6, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by José Antonio González Jurado, PhD, Universidad Pablo de Olavide
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 6, 2023